Hudson Bay Capital Management’s Exact Sciences EXAS Stock Holding History

Hudson Bay Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,115,996	Closed	-$113M	–	1460
2025 Q4	$113M	Buy	+1,115,996	New	+$89.6M	0.37%	58

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Hudson Bay Capital Management's EXAS Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,115,996 shares — an estimated $113M sold.

Hudson Bay Capital Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $113M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Hudson Bay Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 1,115,996 Exact Sciences shares in Q1 2026, an estimated $113M.
Hudson Bay Capital Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
Hudson Bay Capital Management's Exact Sciences position peaked at $113M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.